Publisher: John Wiley and Sons Inc.
Journal: HIV Medicine
Subjects: symptoms, anxiety, ageing, HIV, wellbeing, Original Research, depression
: HIV infection, and potentially its treatment, increases the risk of an arterial ischemic stroke. Multiple etiologies and lack of clear case definitions inhibit progress in this field. Several etiologies, many treatable, are relevant to HIV-related stroke. To fully understand the mechanisms and the terminology used, a robust classification algorithm to help ascribe the various etiologies is needed. This consensus paper considers the strengths and limitations of current case definitions in the context of HIV infection. The case definitions for the major etiologies in HIV-related strokes were refined (e.g., varicella zoster vasculopathy and antiphospholipid syndrome) and in some instances new case definitions were described (e.g., HIV-associated vasculopathy). These case definitions provided a framework for an algorithm to help assign a final diagnosis, and help classify the subtypes of HIV etiology in ischemic stroke.
OBJECTIVES: An increasing proportion of people living with HIV are older adults, who may require specialized care. Adverse physical and psychological effects of HIV infection may be greatest among older people or those who have lived longer with HIV.
METHODS: The ASTRA study is a cross-sectional questionnaire study of 3258 HIV-diagnosed adults (2248 men who have sex with men, 373 heterosexual men and 637 women) recruited from UK clinics in 2011-2012. Associations of age group with physical symptom distress (significant distress for at least one of 26 symptoms), depression and anxiety symptoms (scores ≥ 10 on PHQ-9 and GAD-7, respectively), and health-related functional problems (problems on at least one of three domains of the Euroqol 5D-3L)) were assessed, adjusting for time with diagnosed HIV infection, gender/sexual orientation and ethnicity.
RESULTS: The age distribution of participants was: < 30 years, 5%; 30-39 years, 23%; 40-49 years, 43%; 50-59 years, 22%; and ≥ 60 years, 7%. Overall prevalences were: physical symptom distress, 56%; depression symptoms, 27%; anxiety symptoms, 22%; functional problems, 38%. No trend was found in the prevalence of physical symptom distress with age [adjusted odds ratio (OR) for trend across age groups, 0.96; 95% confidence interval (CI) 0.89, 1.04; P = 0.36]. The prevalence of depression and anxiety symptoms decreased with age [adjusted OR 0.86 (95% CI 0.79, 0.94; P = 0.001) and adjusted OR 0.85 (95% CI 0.77, 0.94; P = 0.001), respectively], while that of functional problems increased (adjusted OR 1.28; 95% CI 1.17, 1.39; P < 0.001). In contrast, a longer time with diagnosed HIV infection was strongly and independently associated with a higher prevalence of symptom distress, depression symptoms, anxiety symptoms, and functional problems (P < 0.001 for trends, adjusted analysis).
CONCLUSIONS: Among people living with HIV, although health-related functional problems were more common with older age, physical symptom distress was not, and mental health was more favourable. These results suggest that a longer time with diagnosed HIV infection, rather than age, is the dominating factor contributing to psychological morbidity and lower quality of life.
The results below are discovered through our pilot algorithms. Let us know how we are doing!
- 1 May M, Gompels M, Sabin C. Life expectancy of HIV-1- positive individuals approaches normal conditional on response to antiretroviral therapy: UK collaborative HIV cohort study. J Int AIDS Soc 2012; 15(Suppl 4): 18078.
- 2 Public Health England. HIV in the United Kingdom: 2014 report. Public Health England, UK, 2014.
- 3 UNAIDS. AIDS by the numbers. UNAIDS Corporate
- 9 Friis-Møller N, Weber R, Reiss P et al. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. Clin Sci 2003; 17: 1179-1193.
- 10 Calza L, Manfredi R, Chiodo F. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. J Antimicrob Chemother 2004; 53: 10-14.
- 11 Thomas J, Doherty SM. HIV infection - a risk factor for osteoporosis. J Acquir Immune Defic Syndr 2003; 33: 281-291.
- 12 Marzolini C, Back D, Weber R et al. Ageing with HIV: medication use and risk for potential drug-drug interactions. J Antimicrob Chemother 2011; 66: 2107-2111.
- 13 Capeau J. Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses. Clin Infect Dis 2011; 68: 1354-1359.
- 14 Smith RD, Delpech VC, Brown AE, Rice BD. HIV transmission and high rates of late diagnoses among adults aged 50 years and over. AIDS 2010; 24: 2109-2115.
- 15 Oursler KK, Goulet JL, Leaf DA et al. Association of comorbidity with physical disability in older HIV-infected adults. AIDS Patient Care STDS 2006; 20: 782-791.
- 16 Stoff DM. Mental health research in HIV/AIDS and aging: problems and prospects. AIDS 2004; 18: S3-S10.
- 17 Miners A, Phillips A, Kreif N et al. Health-related quality-oflife of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population. Lancet HIV 2014; 1: e32-40.
- 18 Nokes KM, Coleman CL, Hamilton MJ et al. Age-related effects on symptom status and health-related quality of life in persons with HIV/AIDS. Appl Nurs Res 2011; 24: 10- 16.
- 19 Frain J, Barton-Burke M, Bachman J et al. A comparison of medication management between older and younger adults living with HIV. J Assoc Nurses AIDS Care 2014; 25: 414-26.
- 20 Speakman A, Rodger A, Phillips AN et al. The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) study. Design, methods and participant characteristics. PLoS ONE 2013; 8: e77230.
- 21 Webber K, Davis AN. Validity of the memorial symptom assessment scale-short form psychological subscales in advanced cancer patients. J Pain Symptom Manage 2011; 42: 761-767.
- 22 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
- 23 Spitzer RL, Kroenke K, Williams JB. A brief measure forassessing generalised anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-1097.
- 24 Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med 2001; 33: 337-343.
- 25 Lifson AR, Grandits GA, Gardner EM et al. Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med 2015; 16(Suppl 1): 88-96.
- 26 Siegel K, Lekas HM, Schrimshaw EW, Brown-Bradley CJ. Strategies adopted by late middle-age and older adults with HIV/AIDS to explain their physical symptoms. Psychol Health 2011; 26: 41-62.
- 27 Solomon P, O'Brien K, Wilkins S, Gervais N. Aging with HIV and disability: the role of uncertainty. AIDS Care 2014; 26: 240-5.
- 28 King SD, Orel N. Midlife and older gay men living with HIV/ AIDS: the influence of resiliency and psychosocial stress factors on health needs. J Gay Lesbian Soc Serv 2012; 24: 346-370.
- 29 Emlet CA, Tozay S, Raveis VH. “I'm not going to die from the AIDS”: resilience in aging with HIV disease. Gerontologist 2011; 51: 101-111.
- 30 Heckman TG, Heckman BD, Kochman A, Sikkema KJ, Suhr J, Goodkin K. Psychological symptoms among persons 50 years of age and older living with HIV disease. Aging Ment Health 2002; 6: 121-128.
- 31 Rabkin JG, McElhiney MC, Ferrando SJ. Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence. AIDS 2004; 18: 43-48.
- 32 Heckman TG, Kochman A, Sikkema KJ. Depressive symptoms in older adults living with HIV disease: application of the chronic illness quality of life model. J Ment Health Aging 2002; 8: 267-279.
- 33 Havlik RJ. Multimorbidity and depression in HIV-infected older adults. Psychol AIDS Exchange Newsl 2014. http:// www.apa.org/pi/aids/resources/exchange/2014/01/multimorbidity.aspx.
- 34 Vance DE, Robinson FP. Reconciling successful aging with HIV: a biopsychosocial overview. J HIV AIDS Soc Serv 2004; 3: 59-78.
- 35 Kahana E, Kahana B. Successful aging among people with HIV/AIDS. J Clin Epidemiol 2001; 54: S53-S56.
- 36 Wagnild G, Young H. Development and psychometric evaluation of the resilience scale. J Nurs Meas 1993; 1: 163- 177.
- 37 Vance DE, Struzick TC, Masten J. Hardiness, successful aging, and HIV: implications for social work. J Gerontol Soc Work 2008; 51: 260-283.
- 38 Skevington SM. Is quality of life poorer for older adults with HIV/AIDS?International evidence using the WHOQOLHIV. AIDS Care 2012; 24: 1219-25.
- 39 Holmes WC, Shea JA. A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: development, reliability, and validity. Med Care 1998; 36: 138-154.
- 40 Vance DE, McGuinness T, Musgrove K, Orel NA, Fazeli PL. Successful aging and the epidemiology of HIV. Clinical interventions in aging. Clin Interv Aging 2011; 6: 181-192.
- 41 Cuevas JE, Vance DE, Viamonte SM, Lee SK, South JL. A comparison of spirituality and religiousness in older and younger adults with and without HIV. J Spiritual Ment Health 2010; 12: 273-287.
- 42 Rauer AJ, Sabey A, Jensen JF. Growing old together: compassionate love and health in older adulthood. J Soc Pers Relat 2013; 31: 677-696.
- 43 Catz SL, Heckman TG, Kochman A, Dimarco M. Rates and correlates of HIV treatment adherence among late middleaged and older adults living with HIV disease. Psychol Health Med 2001; 6: 47-58.
- 44 Greenbaum AH, Wilson LE, Keruly JC, Moore RD, Gebo KA. Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals. AIDS 2008; 22: 2331-2339.
- 45 Grow SL, Yeung P, Towers A, Alpass F, Stephens C. The impact of mobility on quality of life among older persons. J Aging Health 2013; 25: 723-736.
No related research data.
No similar publications.